mar 99 has been researched along with ketotifen in 1 studies
Studies (mar 99) | Trials (mar 99) | Recent Studies (post-2010) (mar 99) | Studies (ketotifen) | Trials (ketotifen) | Recent Studies (post-2010) (ketotifen) |
---|---|---|---|---|---|
6 | 0 | 0 | 1,212 | 275 | 151 |
Protein | Taxonomy | mar 99 (IC50) | ketotifen (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.16 | |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.838 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 1.009 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.374 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.187 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 1.112 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.71 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.537 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 2.209 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.872 | |
Histamine H2 receptor | Homo sapiens (human) | 4.129 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 3.727 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.031 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.16 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 2.537 | |
Histamine H1 receptor | Homo sapiens (human) | 0.0011 | |
D(3) dopamine receptor | Homo sapiens (human) | 1.963 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.046 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 1.141 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishiguro, I; Kobayashi, T; Nishida, K; Ohta, Y | 1 |
1 other study(ies) available for mar 99 and ketotifen
Article | Year |
---|---|
Relationship between changes of active oxygen metabolism and blood flow and formation, progression, and recovery of lesions is gastric mucosa of rats with a single treatment of compound 48/80, a mast cell degranulator.
Topics: Animals; Cell Degranulation; Gastric Mucosa; Glutathione Peroxidase; Hexosamines; Ketotifen; Lipid Peroxides; Male; Mast Cells; Oxygen Consumption; p-Methoxy-N-methylphenethylamine; Peroxidase; Pyrimidines; Rats; Rats, Wistar; Regional Blood Flow; Reperfusion Injury; Sulfhydryl Compounds; Vitamin E; Xanthine Oxidase | 1997 |